Introduction The DEW (Diabetes Education and Wellness) Clinic is an interprofessional, student-led initiative that provides diabetes care through both in-person and telehealth formats. This model offers a unique platform to explore the effectiveness of interdisciplinary collaboration while enhancing student learning and addressing patient care needs in a community-based setting. Methods This article synthesizes findings from three mixed-methods studies conducted between 2022 and 2024. Study 1 evaluated the effectiveness of hybrid (telehealth and in-person) care delivery in diabetes management. Study 2 assessed patient satisfaction, perceived care quality, and outcomes. Study 3 explored student and faculty experiences in the clinic through surveys and focus groups. Participants included adult patients with diabetes, student providers from medicine, pharmacy, etc., and interprofessional faculty mentors. Results The hybrid care model was found to improve access and continuity of care for patients with diabetes, with telehealth appointments providing flexibility and convenience. Patients reported high satisfaction, particularly noting the personalized education and supportive interprofessional approach. Students described enhanced confidence, communication skills, and understanding of interprofessional roles. Faculty mentors valued the opportunity to guide learners in real-time collaborative care. Across all studies, the interprofessional model was viewed as effective in promoting both high-quality patient care and meaningful educational experiences. Conclusion The DEW Clinic exemplifies a scalable, interprofessional approach to chronic disease management that benefits both learners and patients. Integrating telehealth with in-person services enhances accessibility and patient engagement while offering a dynamic educational environment for health professions students. These findings support the continued development and replication of similar interprofessional models in community-based chronic care settings.

Family Physicians' Perspectives on Providing Living Kidney Donor Care.

To determine the net cost of non-drug interventions that maintain or improve a person with dementia's physical function and/or reduce challenging behaviors. Cost data are needed to inform the adoption of non-drug interventions in health systems and the development of policies to incentivize their use. We modified a person-level microsimulation to model the cost of four non-drug interventions relative to usual care: Collaborative Care, Care of Persons with Dementia in their Environments (COPE), Tailored Activity Program (TAP), and Skills2Care. We also conducted a value of information analysis to quantify the optimal sample size of conducting a new randomized trial that would reduce uncertainty on the cost savings of each intervention from a societal perspective. Finally, we conducted sensitivity analyses. Collaborative Care, TAP and COPE were cost savings compared to usual care (-$572, -$1,816, and -$5,262, respectively). Skills2Care results in a $89 net increase in cost compared to usual care. The value of information analysis identified the optimal sample size of a potential future study: Skills2Care (optimal n = 8,560), TAP (optimal n = 5,650), COPE (optimal n = 3,910) and Collaborative Care (optimal n = 3,630). In one-way sensitivity analyses, when we applied a pessimistic assumption for the treatment effect, COPE and TAP were still cost saving, while Collaborative Care cost more than usual care. Conclusions did not materially change in sensitivity analyses that varied treatment cost. Non-drug dementia care interventions that maintain or improve a person with dementia's function and/or reduce challenging behaviors present a viable clinical / economic model of care for health systems.

Current antidementia drugs can temporarily slow cognitive decline in Alzheimer's disease but are underused. Regional and socioeconomic disparities, including limited specialist access in rural or deprived areas, may exacerbate inequities and challenge the rollout of emerging disease-modifying therapies. This study aimed to evaluate associations between regional contextual factors and antidementia drug prescription (AD-Rx) among newly diagnosed people living with Alzheimer's disease (PlwAD) in Germany and to identify spatial clustering of prescribing patterns. This study analyzed anonymized claims data from three statutory health insurers for 53,753 PlwAD who received their first diagnosis between January 2020 and December 2022. Regions, defined by three-digit postal codes (ZIP3, n = 576), were categorized by the German Index of Socioeconomic Deprivation (GISD) quintiles and Degree of Urbanization (urban, suburban, rural). Multilevel logistic regression with random intercepts for ZIP3 was used to assess associations between receiving AD-Rx (dichotomous) and urbanization and deprivation, adjusting for age, sex, the Charlson Comorbidity Index, the long-term care level and the year of diagnosis. Global Moran's I was used to evaluate large-scale spatial clustering, and regional Moran's I was calculated to detect regional hotspots and coldspots. Overall, 64% of PlwAD received at least one AD-Rx. Rural residency was associated with slightly lower odds of receiving AD-Rx compared to urban areas (OR 0.92; 95%CI 0.87-0.98; p = 0.010), whereas deprivation was not. Interaction models demonstrated that an increased deprivation further reduced AD-Rx odds in rural areas (OR per GISD unit = 0.98; 95% CI 0.96-0.99; p = 0.024). Global Moran's I revealed no significant large-scale clustering (I = 0.011; p = 0.613), but regional analysis identified several regional hotspots (high-high clusters) predominantly in moderately deprived urban areas and coldspots (low-low clusters) in highly deprived or rural areas. Alzheimer's patients in rural and high-deprivation regions face limited access to recommended antidementia medications. Targeted interventions, such as teleconsultations, expanding specialist outreach, and collaborative care models in underserved areas, as well as regional dementia networks and national registries, could promote the equitable delivery of current and future Alzheimer's antibody therapies. However, further qualitative and quantitative research is needed to identify the underlying regional causes of these treatment disparities. DRKS00031944.

Background Medications, while essential therapeutic tools in modern healthcare, carry the inherent risk of causing adverse drug events (ADEs) that can result in significant morbidity, mortality, and healthcare costs. Despite substantial research efforts in this domain, the majority of ADEs remain undetected due to reliance on voluntary reporting systems and inadequate surveillance mechanisms. Consequently, the true scope and impact of ADEs are likely far greater than currently recognized. Objective To examine the role of shared clinical decision support (SCDS) in reducing adverse drug events and enhancing patient safety outcomes through systematic integration of clinical decision support systems with shared decision-making frameworks. Methods We conducted a narrative review of literature published up to June 2025, utilizing validated patient safety frameworks to identify contextual factors, systemic challenges, and evidence-based strategies that influence adverse drug event occurrence and prevention. Results Multiple interconnected factors contribute to ADE susceptibility, including healthcare provider competencies (inadequate monitoring, symptom recognition failures), clinical environment characteristics (technology workarounds, equipment complexity), pharmacy system factors (high-risk medication storage, limited pharmacist involvement), and patient-specific variables (polypharmacy, multimorbidity, age-related physiological changes). Critical risk determinants include provider fatigue and burnout, inadequate monitoring protocols, medication administration errors, and systemic communication failures. Successful implementations require multifaceted approaches integrating health information technology components, stakeholder engagement, customized clinical decision rules, and continuous quality improvement processes. Conclusions Shared clinical decision support represents a paradigm shift toward patient empowerment, enabling active patient participation in healthcare decisions while leveraging technology-enhanced clinical guidance. The most promising approach to ADE elimination involves a comprehensive integration of educational initiatives, human factors engineering, robust shared clinical decision support systems, and multidisciplinary collaborative care models.

Introduction: Advancements in diabetes technology have transformed diabetes management, yet technology implementation remains inconsistent due to barriers at both the clinician and patient levels. Team-based collaborative care offers a promising strategy to bridge these gaps. Framework: The Practical, Robust Implementation and Sustainability Model (PRISM), which incorporates the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework, was applied to identify clinician and patient-level barriers to technology implementation and guide development of team-based strategies for improvement. Application of this framework is illustrated through a rural primary care clinic implementing a remote patient monitoring program. Results: Analysis across RE-AIM domains identified team-based, interprofessional strategies for enhancing technology implementation and sustainability. Recommended strategies include structured onboarding and digital literacy support for both patients and clinicians, clear delineation of team roles and intentional integration of workflows, continuous quality improvement through feedback and huddles, and sustained organizational and policy support that ensures security, reimbursement, and equitable access. Conclusions: Application of the PRISM framework to improve diabetes technology implementation allows for translation of technological innovation into meaningful outcomes.

BackgroundMultidisciplinary collaboration emerges as the cornerstone of effective antimicrobial resistance (AMR) prevention in modern healthcare. With MDR infections threatening to claim 10 million lives annually by 2050, the urgency for integrated healthcare solutions has never been greater. Sir Alexander Fleming's early warnings about AMR now resonate powerfully as the COVID-19 pandemic has accelerated the need for robust antimicrobial stewardship (AMS) programmes that unite doctors, pharmacists and nurses in a coordinated fight against superbugs.1 This research reveals how pandemic-driven healthcare transformations can strengthen our defence against one of medicine's most significant challenges.2,3ObjectivesTo investigate how multidisciplinary antimicrobial stewardship practices evolved during COVID-19, examining healthcare professionals' collaborative approaches to antibiotic prescribing, resistance prevention and patient safety optimization across pre-pandemic and pandemic periods at an NHS Foundation Trust in the East of England.MethodsThis comprehensive three-study investigation employed mixed-methods approaches to capture the full spectrum of antimicrobial stewardship evolution. Study 1 systematically reviewed global AMS implementation strategies using rigorous postpositivist methodology. Study 2 retrospectively analysed 640 patient records across pre-pandemic and pandemic periods, utilizing SPSS statistical analysis to identify prescribing pattern changes. Study 3 prospectively surveyed 240 healthcare professionals (doctors, pharmacists, nurses) using validated questionnaires, employing descriptive statistics and regression analysis to quantify attitude shifts and practice modifications during the pandemic.ResultsRevolutionary findings emerged across all studies. Study 1 demonstrated that 92% of successful AMS programmes featured multidisciplinary teams integrating infectious disease physicians, clinical microbiologists and pharmacists, with effective communication proving crucial for implementation success. Study 2 revealed enhanced collaborative care during the pandemic, with pharmacist involvement in antimicrobial decisions increasing from 19% to 21%, signalling strengthened interdisciplinary cooperation. Study 3 uncovered significant awareness shifts, with 42% of professionals acknowledging COVID-19's amplification of antimicrobial resistance risks, while 60% of pharmacists reported increased enthusiasm for AMS activities. However, compliance with local antimicrobial guidelines remained challenging at approximately 22%, highlighting implementation gaps requiring targeted AMS intervention.ConclusionsMultidisciplinary antimicrobial stewardship represents the future of infection control and resistance prevention in healthcare. This research provides compelling evidence that collaborative approaches between doctors, pharmacists and nurses are not merely beneficial but essential for combating AMR, particularly during health crises like COVID-19. The pandemic has catalysed unprecedented cooperation among healthcare professionals, creating opportunities to strengthen antimicrobial stewardship programmes through enhanced communication, shared decision-making and integrated care pathways. These findings offer actionable insights for healthcare organizations worldwide seeking to optimize their antimicrobial use policies and protect patients from the growing threat of drug-resistant infections.

Radiological imaging is essential in clinical practice to support diagnosis and treatment planning. As Physical Therapists (PTs) increasingly collaborate within multidisciplinary teams, their ability to interpret radiographs has become more relevant. In Saudi Arabia, limited data exist concerning the involvement of PTs in radiological interpretation. Therefore, this study aimed to explore PTs' engagement with radiological information, assess their attitudes, and examine the factors influencing their involvement in and interest in imaging education. This cross-sectional descriptive study employed a self-structured questionnaire to gather data on demographics, professional characteristics, practice patterns, learning sources, perceived barriers, and attitudes. Chi-square tests were used to assess associations, and binary logistic regression was used to identify predictors of interest in further education. Among the 241 PTs surveyed, 46.1% reported frequent involvement in radiological interpretation, and 83.0% believed it should be part of their professional role. Academic education was the main learning source, while 40.0% identified insufficient training as a key barrier. Engagement levels and attitudes were significantly associated with qualification, experience, workplace setting, and specialization. Notably, PTs who rarely contributed were four times more likely to express interest in further education (OR = 4.0, 95% CI: 1.5-10.4, ationalificp = 0.007). Many PTs in Saudi Arabia reported engaging in radiological interpretation, though the extent and accuracy of these contributions remain self-reported rather than objectively confirmed. Their involvement was influenced by education, clinical experience, and workplace setting. The findings highlight the need to integrate imaging content into national curricula and continuing professional development programs. Enhancing these competencies has the potential to strengthen collaborative care and may contribute to improved clinical decision-making and healthcare outcomes. Not applicable.

Electronic health record-facilitated symptom surveillance and collaborative care intervention in oncology (E2C2): a cluster-randomised, population-level, stepped-wedge, pragmatic trial.

Protocol for a type 1 hybrid effectiveness implementation trial to evaluate whether a technology-based collaborative care model is non-inferior to remote blood pressure monitoring on persistent hypertension and preventive care attendance among postpartum people with hypertension.

This study aimed to identify core shared competencies required for effective physician-nurse collaboration in primary care. A three-round Delphi survey was conducted from November 2024 to February 2025 with 30 experts (12 physicians, 18 nurses), including family medicine professors, primary care physicians, nursing professors, and practicing nurses. Experts evaluated the importance and roles of interprofessional team approaches using online questionnaires. Quantitative analyses included mean, standard deviation, and content validity ratio (CVR). The first round confirmed the necessity of interprofessional teamwork in cases such as chronic disease management, rehabilitation, elderly care, and mental health. Essential team members were physicians, nurses, and social workers, with additional professionals engaged as needed. Through iterative consensus, six shared competencies were derived: (1) patient-centered integrated care, (2) treatment plan development and implementation, (3) communication and collaboration, (4) professional development as a team member, (5) Evaluation and feedback on service outcomes, and (6) disease prevention and health promotion. All items met consensus criteria (CVR ≥0.34). These findings clarify physician-nurse shared competencies in primary care and provide a foundation for developing competency-based interprofessional curricula and training programs to enhance collaborative care quality and patient outcomes.

Healthcare workers' perceptions of burn care in New South Wales (NSW): guiding a burn model of care.

Early palliative care collaboration for paediatric patients with inherited jaw conditions-a traffic light system.

The Effect of Specialized Collaborative Nursing on the Awakening Quality and Stress Status of Elderly Patients Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Study.

The impact of collaborative pharmaceutical care on hospital discharge medication error prevalence: A stepped-wedge cluster randomised trial.

Aeromedical Retrieval of Critically Ill Pulmonary Embolism Patients: A Retrospective Cohort Study of 10 Years in New South Wales.

A Contemporary Paradigm for Value-Based Medicine in Vascular Care: Challenges and Opportunities.

The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.

Healthcare providers' perspectives on collaboration of care for acute cystitis in women and the role of the community pharmacy: A qualitative study

The Skin: A Critical Window into Chronic Kidney Disease and a Call for Collaborative Care